Serum Amyloid A Is Present in Human Saccular Intracranial Aneurysm Walls and Associates With Aneurysm Rupture

Abstract Saccular intracranial aneurysm (sIA) rupture leads to a disabling subarachnoid hemorrhage. Chronic inflammation and lipid accumulation in the sIA wall contribute to wall degenerative remodeling that precedes its rupture. A better understanding of the pathobiological process is essential for improved future treatment of patients carrying sIAs. Serum amyloid A (SAA) is an acute-phase protein produced in response to acute and chronic inflammation and tissue damage. Here, we studied the presence and the potential role of SAA in 36 intraoperatively resected sIAs (16 unruptured and 20 ruptured), that had previously been studied by histology and immunohistochemistry. SAA was present in all sIAs, but the extent of immunopositivity varied greatly. SAA immunopositivity correlated with wall degeneration (p = 0.028) and rupture (p = 0.004), with numbers of CD163-positive and CD68-positive macrophages and CD3-positive T lymphocytes (all p < 0.001), and with the expression of myeloperoxidase, matrix metalloproteinase-9, prostaglandin E-2 receptor, and cyclo-oxygenase 2 in the sIA wall. Moreover, SAA positivity correlated with the accumulation of apolipoproteins A-1 and B-100. In conclusion, SAA occurs in the sIA wall and, as an inflammation-related factor, may contribute to the development of a rupture-prone sIA.

[1]  A. von Eckardstein,et al.  Transendothelial transport of lipoproteins. , 2020, Atherosclerosis.

[2]  B. Hazenberg,et al.  Causes of AA amyloidosis: a systematic review , 2019, Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis.

[3]  J. Bernaudin,et al.  Expression of SAA1, SAA2 and SAA4 genes in human primary monocytes and monocyte-derived macrophages , 2019, PloS one.

[4]  Ira Tabas,et al.  Inflammation and its resolution in atherosclerosis: mediators and therapeutic opportunities , 2019, Nature Reviews Cardiology.

[5]  P. Kovanen,et al.  Macrophage Infiltration in the Saccular Intracranial Aneurysm Wall as a Response to Locally Lysed Erythrocytes That Promote Degeneration , 2018, Journal of neuropathology and experimental neurology.

[6]  Juha Hernesniemi,et al.  Inflammatory changes in the aneurysm wall: a review , 2018, Journal of NeuroInterventional Surgery.

[7]  P. Kovanen,et al.  Myeloperoxidase Associates With Degenerative Remodeling and Rupture of the Saccular Intracranial Aneurysm Wall , 2018, Journal of neuropathology and experimental neurology.

[8]  F Mut,et al.  Flow Conditions in the Intracranial Aneurysm Lumen Are Associated with Inflammation and Degenerative Changes of the Aneurysm Wall , 2017, American Journal of Neuroradiology.

[9]  Petri T. Kovanen,et al.  Smooth Muscle Cell Foam Cell Formation, Apolipoproteins, and ABCA1 in Intracranial Aneurysms: Implications for Lipid Accumulation as a Promoter of Aneurysm Wall Rupture , 2016, Journal of neuropathology and experimental neurology.

[10]  Hui Liu,et al.  Serum amyloid A stimulates vascular endothelial growth factor receptor 2 expression and angiogenesis , 2016, Journal of Physiology and Biochemistry.

[11]  S. Subramanian,et al.  Serum amyloid A impairs the antiinflammatory properties of HDL. , 2016, The Journal of clinical investigation.

[12]  Haitao Guo,et al.  Inflammasomes: mechanism of action, role in disease, and therapeutics , 2015, Nature Medicine.

[13]  R. Charnigo,et al.  Deficiency of Endogenous Acute-Phase Serum Amyloid A Protects apoE−/− Mice From Angiotensin II–Induced Abdominal Aortic Aneurysm Formation , 2015, Arteriosclerosis, thrombosis, and vascular biology.

[14]  Zong Zhuang,et al.  Increased Expression of NLRP3 Inflammasome in Wall of Ruptured and Unruptured Human Cerebral Aneurysms: Preliminary Results. , 2015, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.

[15]  N. Webb,et al.  A brief elevation of serum amyloid A is sufficient to increase atherosclerosis[S] , 2015, Journal of Lipid Research.

[16]  P. Kovanen,et al.  Mast Cells, Neovascularization, and Microhemorrhages are Associated With Saccular Intracranial Artery Aneurysm Wall Remodeling , 2014, Journal of neuropathology and experimental neurology.

[17]  S. Juvela,et al.  Lifelong Rupture Risk of Intracranial Aneurysms Depends on Risk Factors: A Prospective Finnish Cohort Study , 2014, Stroke.

[18]  Petri Honkanen,et al.  Loss of Mural Cells Leads to Wall Degeneration, Aneurysm Growth, and Eventual Rupture in a Rat Aneurysm Model , 2014, Stroke.

[19]  S. Ylä-Herttuala,et al.  Lipid accumulation, lipid oxidation, and low plasma levels of acquired antibodies against oxidized lipids associate with degeneration and rupture of the intracranial aneurysm wall , 2013, Acta neuropathologica communications.

[20]  O. Naggara,et al.  Safety and occlusion rates of surgical treatment of unruptured intracranial aneurysms: a systematic review and meta-analysis of the literature from 1990 to 2011 , 2012, Journal of Neurology, Neurosurgery & Psychiatry.

[21]  S. Manjila,et al.  Cerebral amyloid angiopathy-associated intracerebral hemorrhage: pathology and management. , 2012, Neurosurgical focus.

[22]  Aki Laakso,et al.  Saccular intracranial aneurysm: pathology and mechanisms , 2012, Acta Neuropathologica.

[23]  P. Witting,et al.  The acute-phase protein serum amyloid A induces endothelial dysfunction that is inhibited by high-density lipoprotein. , 2011, Free radical biology & medicine.

[24]  Jean-Baptiste Michel,et al.  Novel aspects of the pathogenesis of aneurysms of the abdominal aorta in humans , 2010, Cardiovascular research.

[25]  Juha Hernesniemi,et al.  Inflammatory changes in the aneurysm wall: a review , 2010, Journal of NeuroInterventional Surgery.

[26]  P. Witting,et al.  Serum amyloid A induction of cytokines in monocytes/macrophages and lymphocytes. , 2009, Atherosclerosis.

[27]  Ale Algra,et al.  Changes in case fatality of aneurysmal subarachnoid haemorrhage over time, according to age, sex, and region: a meta-analysis , 2009, The Lancet Neurology.

[28]  K. Kotani,et al.  A novel oxidized low-density lipoprotein marker, serum amyloid A-LDL, is associated with obesity and the metabolic syndrome. , 2009, Atherosclerosis.

[29]  S. Tam,et al.  Acute-Phase-HDL Remodeling by Heparan Sulfate Generates a Novel Lipoprotein with Exceptional Cholesterol Efflux Activity from Macrophages , 2008, PloS one.

[30]  V. King,et al.  Serum amyloid A, but not C-reactive protein, stimulates vascular proteoglycan synthesis in a pro-atherogenic manner. , 2008, The American journal of pathology.

[31]  M. Baumann,et al.  Serum amyloid A (SAA) activates human mast cells which leads into degradation of SAA and generation of an amyloidogenic SAA fragment. , 2006, Biochimica et biophysica acta.

[32]  W. Landman,et al.  Extrahepatic production of acute phase serum amyloid A. , 2005, Histology and histopathology.

[33]  J. Kwak,et al.  Serum amyloid A stimulates matrix-metalloproteinase-9 upregulation via formyl peptide receptor like-1-mediated signaling in human monocytic cells. , 2005, Biochemical and biophysical research communications.

[34]  Marko Kangasniemi,et al.  Remodeling of Saccular Cerebral Artery Aneurysm Wall Is Associated With Rupture: Histological Analysis of 24 Unruptured and 42 Ruptured Cases , 2004, Stroke.

[35]  K. Migita,et al.  Lipopolysaccharide signaling induces serum amyloid A (SAA) synthesis in human hepatocytes in vitro , 2004, FEBS letters.

[36]  V. Salomaa,et al.  The association of c-reactive protein, serum amyloid a and fibrinogen with prevalent coronary heart disease--baseline findings of the PAIS project. , 2001, Atherosclerosis.

[37]  A. Campa,et al.  A novel function of serum amyloid A: a potent stimulus for the release of tumor necrosis factor-alpha, interleukin-1beta, and interleukin-8 by human blood neutrophil. , 2000, Biochemical and biophysical research communications.

[38]  M. Taneda,et al.  Structural fragility and inflammatory response of ruptured cerebral aneurysms. A comparative study between ruptured and unruptured cerebral aneurysms. , 1999, Stroke.

[39]  G. Nilsson,et al.  Serum amyloid A induces chemotaxis of human mast cells by activating a pertussis toxin-sensitive signal transduction pathway. , 1999, Biochemical and biophysical research communications.

[40]  D. Chyatte,et al.  Vascular extracellular matrix remodeling in cerebral aneurysms. , 1998, Journal of neurosurgery.

[41]  D. Longo,et al.  A novel biologic function of serum amyloid A. Induction of T lymphocyte migration and adhesion. , 1995, Journal of immunology.

[42]  A. Lusis,et al.  Serum amyloid A protein family. Differential induction by oxidized lipids in mouse strains. , 1994, Arteriosclerosis and thrombosis : a journal of vascular biology.

[43]  R. Badolato,et al.  Serum amyloid A is a chemoattractant: induction of migration, adhesion, and tissue infiltration of monocytes and polymorphonuclear leukocytes , 1994, The Journal of experimental medicine.

[44]  S. Urieli-Shoval,et al.  Expression of apolipoprotein serum amyloid A mRNA in human atherosclerotic lesions and cultured vascular cells: implications for serum amyloid A function. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[45]  J L Witztum,et al.  Antisera and monoclonal antibodies specific for epitopes generated during oxidative modification of low density lipoprotein. , 1990, Arteriosclerosis.

[46]  G. Coetzee,et al.  Serum amyloid A-containing human high density lipoprotein 3. Density, size, and apolipoprotein composition. , 1986, The Journal of biological chemistry.

[47]  R. Mahley,et al.  Plasma lipoproteins: apolipoprotein structure and function. , 1984, Journal of lipid research.

[48]  V. Elner,et al.  Immunohistochemical localization of apolipoprotein B in human atherosclerotic lesions. , 1984, Archives of pathology & laboratory medicine.

[49]  K. Sletten,et al.  Characterization of amyloid related protein SAA complexed with serum lipoproteins (apoSAA). , 1982, Clinical and experimental immunology.

[50]  N. Eriksen,et al.  Chemical classes of amyloid substance. , 1971, The American journal of pathology.

[51]  P. Kovanen,et al.  Immune functions of serum amyloid A. , 2012, Critical reviews in immunology.

[52]  T. Kodama,et al.  A serum amyloid A and LDL complex as a new prognostic marker in stable coronary artery disease. , 2004, Atherosclerosis.

[53]  B. Ray,et al.  Mechanism of minimally modified LDL-mediated induction of serum amyloid A gene in monocyte/macrophage cells. , 1999, DNA and cell biology.